Literature DB >> 11207653

Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients.

Z Toossi1, H Mayanja-Kizza, C S Hirsch, K L Edmonds, T Spahlinger, D L Hom, H Aung, P Mugyenyi, J J Ellner, C W Whalen.   

Abstract

Active TB in HIV-1-infected subjects is associated with increased HIV-1-related immunodeficiency and mortality. We assessed plasma viral load in HIV-1-infected patients with pulmonary TB (HIV/TB) and non-TB symptomatic HIV-1-infected patients (HIV). HIV-1 load was higher in HIV/TB compared with HIV at higher CD4 counts (> 500/microl) (P < 0.01), but not at lower CD4 counts (< 500/microl). We also evaluated the status of HIV-1 gene expression in peripheral blood mononuclear cells (PBMC) and serum from HIV/TB and CD4-matched healthy HIV-infected patients (HIV/C) by reverse transcriptase-polymerase chain reaction over a range of CD4 (> 900/microl to < 200/microl). HIV-1 RNA in serum and PBMC correlated to one another, and both were markedly higher in HIV/TB compared with HIV/C with higher CD4 counts. Also, during a longitudinal study of anti-tuberculous chemoprophylaxis in HIV-1-infected patients, 10 subjects who developed TB had serologies before, at the time, and after the diagnosis of TB. These HIV/TB patients had an increase in viral load (average 2.5-fold) at the time of diagnosis of TB (P < 0.05). Overall, these data indicate that the transcriptional activity of HIV-1 is enhanced in HIV-1-infected patients with active TB, especially during early HIV-1 disease. As TB often is an early HIV-1 opportunistic infection, it may particularly favour early viral replication and dissemination, and therefore contribute to progression of HIV-1 disease.

Entities:  

Mesh:

Year:  2001        PMID: 11207653      PMCID: PMC1905977          DOI: 10.1046/j.1365-2249.2001.01401.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users.

Authors:  S B Manoff; H Farzadegan; A Muñoz; J A Astemborski; D Vlahov; R T Rizzo; L Solomon; N M Graham
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

2.  Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans.

Authors:  S D Lawn; R J Shattock; J W Acheampong; R B Lal; T M Folks; G E Griffin; S T Butera
Journal:  AIDS       Date:  1999-11-12       Impact factor: 4.177

3.  Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation.

Authors:  D Goletti; D Weissman; R W Jackson; N M Graham; D Vlahov; R S Klein; S S Munsiff; L Ortona; R Cauda; A S Fauci
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

4.  Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung.

Authors:  K Nakata; W N Rom; Y Honda; R Condos; S Kanegasaki; Y Cao; M Weiden
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

5.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.

Authors:  C Dye; S Scheele; P Dolin; V Pathania; M C Raviglione
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

6.  Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus.

Authors:  M M Lederman; D L Georges; D J Kusner; P Mudido; C Z Giam; Z Toossi
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-07

7.  Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial.

Authors:  R S Wallis; P Nsubuga; C Whalen; R D Mugerwa; A Okwera; D Oette; J B Jackson; J L Johnson; J J Ellner
Journal:  J Infect Dis       Date:  1996-10       Impact factor: 5.226

8.  Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection.

Authors:  G Vanham; K Edmonds; L Qing; D Hom; Z Toossi; B Jones; C L Daley; B Huebner; L Kestens; P Gigase; J J Ellner
Journal:  Clin Exp Immunol       Date:  1996-01       Impact factor: 4.330

9.  Accelerated course of human immunodeficiency virus infection after tuberculosis.

Authors:  C Whalen; C R Horsburgh; D Hom; C Lahart; M Simberkoff; J Ellner
Journal:  Am J Respir Crit Care Med       Date:  1995-01       Impact factor: 21.405

10.  Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1.

Authors:  Z Toossi; J G Sierra-Madero; R A Blinkhorn; M A Mettler; E A Rich
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more
  51 in total

1.  Malaria parasitemia and CD4 T cell count, viral load, and adverse HIV outcomes among HIV-infected pregnant women in Tanzania.

Authors:  Molly F Franke; Donna Spiegelman; Amara Ezeamama; Said Aboud; Gernard I Msamanga; Saurabh Mehta; Wafaie W Fawzi
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

Review 2.  The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis.

Authors:  Ruanne V Barnabas; Emily L Webb; Helen A Weiss; Judith N Wasserheit
Journal:  AIDS       Date:  2011-08-24       Impact factor: 4.177

3.  A structured approach to recording AIDS-defining illnesses in Kenya: A SNOMED CT based solution.

Authors:  Tom Oluoch; Nicolette de Keizer; Patrick Langat; Irene Alaska; Kenneth Ochieng; Nicky Okeyo; Daniel Kwaro; Ronald Cornet
Journal:  J Biomed Inform       Date:  2015-07-13       Impact factor: 6.317

Review 4.  HIV and tuberculosis: a deadly human syndemic.

Authors:  Candice K Kwan; Joel D Ernst
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus.

Authors:  Amita Gupta; Ramesh Bhosale; Arti Kinikar; Nikhil Gupte; Renu Bharadwaj; Anju Kagal; Suvarna Joshi; Medha Khandekar; Alaka Karmarkar; Vandana Kulkarni; Jayagowri Sastry; Vidya Mave; Nishi Suryavanshi; Madhuri Thakar; Smita Kulkarni; Srikanth Tripathy; Pradeep Sambarey; Sandesh Patil; Ramesh Paranjape; Robert C Bollinger; Arun Jamkar
Journal:  J Infect Dis       Date:  2011-02-01       Impact factor: 5.226

6.  Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity.

Authors:  Kalonji R Collins; Miguel E Quiñones-Mateu; Mianda Wu; Henry Luzze; John L Johnson; Christina Hirsch; Zahra Toossi; Eric J Arts
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  Induction of HIV type 1 expression correlates with T cell responsiveness to mycobacteria in patients coinfected with HIV type 1 and Mycobacterium tuberculosis.

Authors:  David H Canaday; Mianda Wu; Shigou Lu; Htin Aung; Pierre Peters; Joy Baseke; Wilma Mackay; Harriet Mayanja-Kizza; Zahra Toossi
Journal:  AIDS Res Hum Retroviruses       Date:  2009-02       Impact factor: 2.205

8.  Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects.

Authors:  Karina I Carvalho; Solange Maeda; Luciana Marti; Jane Yamashita; Patrick A J Haslett; Esper G Kallas
Journal:  Immunology       Date:  2008-02-12       Impact factor: 7.397

Review 9.  Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm.

Authors:  Emily S Ford; Camille E Puronen; Irini Sereti
Journal:  Curr Opin HIV AIDS       Date:  2009-05       Impact factor: 4.283

10.  Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis.

Authors:  Timothy Lahey; Mecky Matee; Lillian Mtei; Muhammad Bakari; Kisali Pallangyo; C Fordham von Reyn
Journal:  BMC Infect Dis       Date:  2009-02-23       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.